English | Español
Jamie Barrand | Sep 20, 2015

Novo Nordisk plans expansions in North Carolina, Denmark
Jamie Barrand | Sep 20, 2015

Research on medication used to treat uterine fibroids moving forward
Jamie Barrand | Sep 20, 2015

PhRMA releases report on cancer medications
Daniel Daw | Sep 18, 2015

Merck issues pancreatitis advisory for users of diabetes drug
Daniel Daw | Sep 18, 2015

Study shows Jardiance reduces cardiovascular risks in patients with Type 2 diabetes
Daniel Daw | Sep 18, 2015

Bristol-Myers Squibb's Opdivo gets FDA OK for use against kidney cancer

Jamie Barrand | Sep 18, 2015

Spriva Respimat approved by FDA for maintenance treatment of asthma
Jamie Barrand | Sep 18, 2015

Proposed policies could hinder U.S. medical progress

Trending
+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’
+ Pharmaceuticals
Patient Daily | Jun 23, 2025

PhRMA says patients in the U.S. face higher prescription costs due to 340B program
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'